SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001257433-03-000010
Filing Date
2003-09-24
Accepted
2003-09-24 15:39:40
Documents
1
Period of Report
2003-09-22

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3904
  Complete submission text file 0001257433-03-000010.txt   5619
Mailing Address 301 CONGRESS AVE SUITE 1850 AUSTIN TX 78701
Business Address 301 CONGRESS AVE SUITE 1850 AUSTIN TX 78701 5127089310
INTROGEN THERAPEUTICS INC (Issuer) CIK: 0001018710 (see all company filings)

IRS No.: 742704230 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address 2250 HOLCOMBE BLVD HOUSTON TX 77030 7137979960
MERRITT JAMES A (Reporting) CIK: 0001264529 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-21291 | Film No.: 03908072